Honestly, the crazy leaders we have should be broadcasting this from the rooftops due to the fact it adds to the herd immunity stats. But, ultimately, no huge vaccine money in natural immunity...I mean, what else can you make of it?
And they should take pictures in ICUs with people on ventilators so they can put those pictures on their campaign literature while they tout their herd immunity policies.
I understand the difference, I'm asking if there is any evidence that forming an antibody from different epitopes on Covid other than the spike protein has greater immunity or longer duration. That takes a few years to determine, so was genuinely asking why such a definitive statement was made.
Not to paint with a broad brush, but I will for the sake of argument. Most people I know who aren’t vaccinated believe the virus originated in a lab and was manipulated to be more infectious/deadly. And at the same time they believe the vaccine is still experimental and we don’t know the long term effects. So they’d rather take their chances in getting and recovering from a man-made virus than taking a man-made vaccine. Doesn’t logically make sense to me, but to each their own. The proof is in the numbers for how well the vaccine prevents severe illness and death. The public data from Florida shows an obvious relationship between vaccination rate and positivity rate. Look at Miami-Dade, the most populous and highly vaccinated county in Florida has the lowest new case positivity rate. Daily hospital statistics from Dade consistently show around 90% of patients are unvaccinated while the vaccination rate for people 12+ is close to 90%…if the vaccine didn’t work you would expect the opposite numbers.
My antibodies have lasted just as long or longer than the short term shot you and other have taken, Translation get ready for another shot
. Where did I say that? Please don’t make up what I didn’t say and attribute It to me. I presume You do not realize that the COVID ICUs are dedicated wards. Otherwise, you would not reply with a statement like that. You evidently don’t believe the news and reports on hospitalizations because they don’t move you at all.
Look, I think we are gonna get in trouble dumping on the thread. I took it for all the reasons you guys say, but we will never see eye to eye on using govt force to deprive someone of their livelihood or keep people from living their lives as they see fit. Anyway don't much feel like arguing anymore, just now found out the noles lost last night.
Definitively? Certainly not based on what I understand. The statements are being made based largely on half-life studies such as the ones reported on in the linked paper below. (again, I am not an expert and some of the subtlety is lost on me) In addition to the paper, here is a podcast where one of the co-authors is interviewed on this subject. The first 45 minutes he goes through the findings to date on the subject of immunity derived by infection vs immunity derived from vaccine vs the combination. TWiV 802: Another epitope with Shane Crotty AAAS
Well, it is good that the Noles lost and you found out. I empathize that you had to wait until tonight to learn the good news and how they lost. I went to sleep before the end of the game, but a buddy on the insider board i text with texted us this AM with the link. So, something to smile about all day!
Remember that people get colds from other coronaviruses more than once. So we can anticipate that vaccine immunity and post-infection immunities will have temporal limits.
No one has created a vaccine for the common cold viruses. Somehow, the immunity from infection paired with a mRNA vaccine shot is doing something that no one can explain. It is actually broadening immunity and evolving the antibodies at an accelerated rate such that when serum drawn from such people is tested in vitro against SARS-CoV, it completely neutralizes it. It is also showing efficacy against MERS. So....what does any of that have to do with your statements? Maybe nothing, and you are 100% right. However, there does seem to be something different this time either with the immune response to the virus itself, or what the mRNA vaccines are doing. Scientists are also reporting that when they perform very laborious studies of extracting cells from lymph nodes and studying the germinal centers that they are seeing T-cell germinal centers 12-16 weeks and even longer after infection/vaccine. Now, that does not mean much to me, but to the immunologists I was listening to, that was an unprecedently long time, suggesting immunity from severe disease could last much, much longer than originally thought. Again, this could all be a pile of conjecture and poop as well.....or, I am not understanding nearly as much as I think I am but. However, something real does seem to be a bit different right now.
I may have started this thread, but it's clearly @ncargat1 's thread now. Can we please be respectful of this posters hard work and take the usual worthless jibber jabber to the jibber jabber thread? Please and thank you
They may just be learning why the coronaviruses just cause colds after exposure. The whole idea behind the vaccines is to trigger the immune system and trach it so it handles the infection. Immunity may wane, but the immune system has learned to react appropriately; it has the memory it would not have encountering an a novel virus. Prior infection is the same, but, ultimately, neither will prevent a coronavirus infection at some point unless boosted.
So to answer my question: you have no idea of the level of antibodies you have. Sounds like a booster is in your future. Or a ventilator?
Molnupiravir trials are seeing healthy enrollments and their executives are telling investors it is possible that they could have the paperwork in to the FDA in time for an EUA by the end of the year. Hopefully the results suggest that this re-purposed medication is more like Tami-flu (for Covid of course) than Remdesivir. This will also stoke a new wave of Q-BS about Merck touting its new, expensive drug over everyone's favorite anti-parasitic drug. Merck sees potential U.S. authorization for COVID-19 antiviral before year-end
